Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 1
First in Human Phase 1 Study of AOH1996 in Patients With Refractory Solid Tumors
This phase I trial studies the side effects and best dose of AOH1996 in treating patients with solid tumors that do not respond to treatment (refractory). AOH1…
Refractory Malignant Solid NeoplasmOsteosarcomaLeiomyosarcomas+4 more
Estimated
~$10 – $6,250
City of Hope Medical CenterNCT05227326
Phase 2
A Non-Randomized, Open-label Phase II Trial Testing the Activity of XL092 (Zanzalintinib) in Patients With Advanced Leiomyosarcoma, Bone Sarcoma or Translocation-associated Soft Tissue Sarcoma
This phase II trial tests how well zanzalintinib (XL092) works in treating patients with leiomyosarcoma that has spread from where it first started to other pl…
Metastatic LeiomyosarcomaUnresectable LeiomyosarcomaBone Sarcoma+7 more
Estimated
~$10 – $6,250
Northwestern UniversityNCT06571734